How long can one live with stage 4 nasopharyngeal cancer? What are the dietary treatments?

How long can you live with stage 4 nasopharyngeal cancer? What are some folk remedies?

1. Generally speaking, the natural course of nasopharyngeal carcinoma from the initial symptoms to death ranges from 3 months to 113 months. According to domestic and foreign reports, the 5-year survival rate after radiotherapy is 8% to 62%. With the update of radiotherapy equipment and the improvement of radiotherapy technology, the 5-year survival rate of nasopharyngeal carcinoma after radiotherapy continues to increase.

2. The survival of nasopharyngeal cancer patients is related to many external factors. The patient's own psychological quality will also affect the survival of nasopharyngeal cancer patients. The most important thing is the correct treatment method. Only by choosing the right method can the disease be controlled and the patient's survival be prolonged.

3. The main treatments for stage 4 NPC include radiotherapy and traditional Chinese medicine. Radiotherapy is the first choice for stage 4 NPC, which has a more direct killing effect on cancer cells, but it can also cause damage to normal cells. The dose, radiation range and radiation course should be carefully selected according to the extent of the lesion and the function of the human body.

Dietary remedies:

Longan paste. 120g of longan pulp, 250g of Codonopsis pilosula, 150g of Adenophora radix, and appropriate amount of honey. Method: Put longan pulp, Codonopsis pilosula, and Adenophora radix into a pot, add appropriate amount of water to soak, simmer for 20 minutes to extract juice once, add water to boil 3 times, and extract juice 3 times in total. Combine the three juices, simmer on low heat until sticky, add honey, boil and turn off the heat, cool, and bottle. Use: Rinse with boiling water. Take 50g 3 times a day for 7 to 10 consecutive days. Efficacy: replenish qi and nourish blood, promote body fluid and moisten dryness, clear heat and nourish yin. Use: Suitable for patients with nasopharyngeal carcinoma who are weak for a long time or weak and leukopenic after postoperative radiotherapy and chemotherapy.